Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 22;111(9):3379–3385. doi: 10.1111/cas.14544

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Levels of inflammatory markers in hematological patients infected with severe acute respiratory syndrome coronavirus 2 and features of chest computed tomography (CT). A, Peak concentrations of inflammatory markers in 9 cases. B‐E, Time course of procalcitonin (PCT) (B), C‐reactive protein (CRP) (C), interleukin‐6 (IL‐6) (D), and ferritin (E) levels in cases 1, 2, and 9. F, CT image from Case 7 shows nodules in the subpleural areas on day 1 after symptom onset. G‐I, Axial images from Case 6 showed bilateral patchy consolidations and pleural effusion before (G) and on day 2 after confirmation of COVID‐19 infection (H), and improvement on day 10 (I). J‐M, CT images from Case 3 showed mixed ground glass opacity with consolidation and a single side pleural effusion on day 3 (J), 13 (K), and 26 (L) after symptom onset, and improvement on day 48 (M)